Vaxcyte, Inc.

PCVX·NASDAQ·$50.11Share Price as of 11/2·$7BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report10/09/26 8-KCurrent report10/05/26 8-KCurrent report09/03/26 8-KCurrent report08/05/26 8-KCurrent report07/15/26

Prospectuses and Registrations

424B5Prospectus supplement10/08/26 424B5Prospectus supplement10/08/26 FWPFree writing prospectus10/07/26 424B5Prospectus supplement10/06/26 424B5Prospectus supplement10/06/26

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 PRE 14APreliminary proxy04/18/25

Ownership

Form 4Insider transaction10/07/26 Form 4Insider transaction10/07/26 144Proposed sale of securities10/05/26 144Proposed sale of securities10/05/26 Form 4Insider transaction10/02/26

Other

305B2305B210/06/26 ARSAnnual report to shareholders04/23/26 UPLOADLetter from the SEC05/14/25 CORRESPCorrespondence with the SEC05/07/25 ARSAnnual report to shareholders04/28/25